Sebivo and blood creatine phosphokinase mb increased Patient Reports February 13, 2012

Sebivo Side Effects Report #6122239-X
Sebivo side effect was reported by a Physician from CHINA on Mar 13, 2009. Male patient, 32 years of age, was diagnosed with hepatitis b  and was treated with Sebivo. After drug was administered, patient experienced the following side effects: abdominal distension, angiopathy, anorexia, arrhythmia , blood creatine phosphokinase increased, blood creatine phosphokinase mb increased, blood pressure decreased, coma, disseminated intravascular coagulation. Sebivo dosage: unknown. During the same period patient was treated with HEPSERA, LAMIVUDINE. Patient was hospitalized. Patient died.

Sebivo Side Effects Report #6125263-6
Sebivo side effect was reported by a Physician from CHINA on Mar 15, 2009. Male patient, 32 years of age, was diagnosed with hepatitis b  and was treated with Sebivo. After drug was administered, patient experienced the following side effects: abdominal distension, angiopathy, anorexia, arrhythmia , arterial catheterisation, atrial hypertrophy, blood creatine phosphokinase increased, blood creatine phosphokinase mb increased, blood pressure decreased. Sebivo dosage: unknown. During the same period patient was treated with HEPSERA, LAMIVUDINE, TAZOCIN, PANTOPRAZOLE, ESSENTIALETE N, COMPOUND GLYCYRRHIZIN, ULINASTATIN, ALPROSTADIL. Patient was hospitalized. Patient died.

Sebivo Side Effects Report #5977372-X
Sebivo side effect was reported by a Consumer or non-health professional from CHINA on Nov 25, 2008. Male patient, 30 years of age, was diagnosed with hepatitis b  and was treated with Sebivo. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase mb increased, cardiovascular disorder, electrocardiogram abnormal, heart rate increased, nodal arrhythmia, palpitations. Sebivo dosage: 600 MG, QD. Patient recovered.

Sebivo Side Effects Report #6051798-0
Sebivo side effect was reported by a Physician from CHINA on Jan 15, 2009. Male patient, 26 years of age, was diagnosed with hepatitis b  and was treated with Sebivo. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, blood creatine phosphokinase mb increased, blood lactate dehydrogenase increased, blood uric acid increased, hypoaesthesia. Sebivo dosage: 600 MG, QD. Patient recovered.


Sebivo Side Effects Report #5965069-1
Sebivo side effect was reported by a Health Professional from CHINA on Nov 17, 2008. Female patient, 20 years of age, was diagnosed with hepatitis b  and was treated with Sebivo. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, blood creatine phosphokinase mb increased, cardiomyopathy , electrocardiogram st segment depression. Sebivo dosage: 600 MG, QD. Patient recovered.

Sebivo Side Effects Report #5838926-4
Sebivo side effect was reported by a Physician from CHINA on Aug 01, 2008. Female patient was diagnosed with hepatitis b  and was treated with Sebivo. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, blood creatine phosphokinase mb increased, myocarditis. Sebivo dosage: unknown. During the same period patient was treated with INTERFERON. Patient was hospitalized. Patient recovered.

Sebivo Side Effects Report #5839678-4
Sebivo side effect was reported by a Physician from CHINA on Aug 01, 2008. Female patient was diagnosed with hepatitis b  and was treated with Sebivo. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, blood creatine phosphokinase mb increased, blood lactic acid increased, blood ph decreased, lactic acidosis, respiratory tract infection, white blood cell count increased. Sebivo dosage: 600 MG, QD. During the same period patient was treated with ADEFOVIR DIPIVOXIL. Patient was hospitalized. Patient died.

Sebivo Side Effects Report #5937107-3
Sebivo side effect was reported by a Physician from CHINA on Oct 21, 2008. Male patient, weighting 94.80 lb, was diagnosed with hepatitis b  and was treated with Sebivo. After drug was administered, patient experienced the following side effects: acinetobacter infection, activated partial thromboplastin time prolonged, altered state of consciousness, anorexia, blood creatine phosphokinase increased, blood creatine phosphokinase mb increased, blood lactic acid increased, blood pressure fluctuation, burkholderia cepacia infection. Sebivo dosage: 600 MG, QD. During the same period patient was treated with ADEFOVIR DIPIVOXIL. Patient was hospitalized. Patient died.

Sebivo Side Effects Report #6106320-7
Sebivo side effect was reported by a Physician from CHINA on Feb 24, 2009. Female patient, 41 years of age, was diagnosed with antiviral treatment and was treated with Sebivo. After drug was administered, patient experienced the following side effects: alpha hydroxybutyrate dehydrogenase increased, apolipoprotein b increased, aspartate aminotransferase increased, blood cholesterol increased, blood creatine phosphokinase increased, blood creatine phosphokinase mb increased, blood creatinine increased, blood lactate dehydrogenase increased, glomerulonephritis chronic. Sebivo dosage: 600 MG/DAY. During the same period patient was treated with HORMONES. Patient was hospitalized. Patient recovered.


Sebivo Side Effects Report #6120429-3
Sebivo side effect was reported by a Physician from CHINA on Mar 11, 2009. Male patient, 32 years of age, was treated with Sebivo. After drug was administered, patient experienced the following side effects: abdominal distension, blood creatine phosphokinase increased, blood creatine phosphokinase mb increased, blood pressure decreased, coma, disseminated intravascular coagulation, dyspnoea, gastrointestinal disorder, lactic acidosis. Sebivo dosage: unknown. During the same period patient was treated with HEPSERA, LAMIVUDINE. Patient was hospitalized. Patient died.

Sebivo Side Effects Report #5904377-7
Sebivo side effect was reported by a Physician from CHINA on Sept 26, 2008. Female patient was treated with Sebivo. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anuria, aspartate aminotransferase increased, blood creatine phosphokinase increased, blood creatine phosphokinase mb increased, blood creatinine increased, blood lactic acid increased, blood urea increased, circulatory collapse. Sebivo dosage: 600 MG, QD. During the same period patient was treated with ENTECAVIR. Patient recovered.